spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  TactiCath 

 HSMN NewsFeed - 4 Aug 2020
Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jan 2019
Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 13 Jan 2017
Abbott Announces U.S. Launch and First Commercial Use of the New EnSite(TM) Precision Cardiac Mapping System
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 5 Oct 2016
St. Jude Medical Announces European Full Market Release of EnSite Precision Cardiac Mapping System
Devices Cardiology Product Launch
 HSMN NewsFeed - 19 Apr 2016
St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark
Devices Cardiology Product Launch
 HSMN NewsFeed - 27 Oct 2014
St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for Treatment of Atrial Fibrillation
Devices Cardiology FDA
 HSMN NewsFeed - 19 Aug 2013
St. Jude Medical Acquires Endosense
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2013
Endosense’s EFFICAS I Study Yields New Contact Force Guidelines in Catheter Ablation Treatment of AF; Findings Published in Circulation: Arrhythmia and Electrophysiology
Devices Cardiology
 HSMN NewsFeed - 5 Mar 2013
Endosense Closes an Additional USD 4.3 Million/CHF 4 Million in Series C Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 1 Feb 2013
First U.S. Case Performed with Endosense’s TactiCath(R) Quartz Contact-Force Sensing Ablation Catheter
Devices Cardiology
 HSMN NewsFeed - 12 Jun 2012
Endosense and BIOTRONIK Announce CE Mark Approval, First Clinical Use of the New TactiCath(R) Quartz Force-Sensing Ablation Catheter
Devices Cardiology Regulatory
 HSMN NewsFeed - 12 Jan 2012
Endosense Launches TactiCath(R) 75 Force-Sensing Catheter, Announces New Results of EFFICAS I Clinical Study
Devices Cardiology
 HSMN NewsFeed - 14 Sep 2011
Endosense Names Jan Keltjens President and Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 5 May 2011
Endosense and BIOTRONIK Mark 1,000th Procedure Performed with the TactiCath(R) Force-Sensing Ablation Catheter
Devices Cardiology
 HSMN NewsFeed - 12 Jan 2011
Endosense Launches the TOCCASTAR IDE Study of Its TactiCath(R) Force-Sensing Ablation Catheter
Devices Cardiology
 HSMN NewsFeed - 15 Jun 2010
Endosense Enrolls First Patients in ProForce, an International Post-Market Study of the TactiCath(R)
Devices Cardiology
 HSMN NewsFeed - 13 May 2010
Endosense Announces 12-Month TOCCATA Study Data Reinforcing Clinical Benefit of the TactiCath(R)
Devices Cardiology
 HSMN NewsFeed - 20 Apr 2010
Endosense Launches Next Generation TactiCath(R) Force-Sensing Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Jan 2010
BIOTRONIK and Endosense Sign International Exclusive Distribution Partnership
Devices Cardiology Distribution
 HSMN NewsFeed - 10 Dec 2009
Endosense Names Jan H. Egberts, M.D. Chairman of the Board, Adds Michael J. Dormer as New Board Director
Devices Cardiology Personnel
 HSMN NewsFeed - 1 Sep 2009
Endosense Closes USD 36 Million / Euro 25 Million Series B Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 15 May 2009
Endosense Unveils TOCCATA Trial Results: The First Complete Assessment of Force in Catheter Ablation
Devices Cardiology
 HSMN NewsFeed - 6 May 2009
Endosense Receives CE Mark for TactiCath Force-Sensing Ablation Catheter
Devices Cardiology Regulatory
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.